RSV clinical trial is now enrolling. Payment up to $440

New York City NY

Description

If you are 65+, you may want to find out more about an RSV clinical trial. The clinical trial will focus on advancing RSV medical knowledge and testing potential new vaccines. Those who qualify may receive: • Payment up to $440, which varies by study • Study-related care from local doctors at no cost • Study medication at no cost Health insurance is not required Visit the study website and see if your eligible, GENETWORx supports the advancement of medicine through clinical research. GENETWORx receives compensation for services provided to build study awareness. We do not share any personal information without consent and in no way are involved in the conduct of the study itself.